Trials / Completed
CompletedNCT01360502
Safety of Capsule Endoscopy in Patients With Implantable Cardiac Devices
Safety of Capsule Endoscopy Using Human Body Communication in Patients With Cardiac Pacemakers and Implantable Cardiac Defibrillators
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective study designed to assess safety and potential influence of the MiroCam on cardiac pacemaker and implantable cardiac defibrillator.
Detailed description
MiroCam (IntroMedic, Ltd, Seoul, Korea) is a small bowel capsule endoscope using human body communication for data transmission. There is a concern of potential interactions between cardiac devices and capsule endoscope. This clinical study was designed to evaluate the potential influence of the MiroCam on cardiac pacemaker and implantable cardiac defibrillator.
Conditions
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2011-02-01
- Completion
- 2011-02-01
- First posted
- 2011-05-25
- Last updated
- 2011-05-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01360502. Inclusion in this directory is not an endorsement.